Developer docs
API playgroundTry for free, no card

Search company profiles

CardioComm Solutions, Inc.

Full company profile

uuid0006bsm

Namestring
CardioComm Solutions, Inc.
Legal namestring
CardioComm Solutions, Inc.
Company typeenum
Public
Founded yearint
1989
Descriptiontext

CardioComm Solutions, Inc. is a Canadian public company listed on the TSX Venture Exchange (ticker: EKG) that develops and commercializes proprietary ECG software platforms for remote cardiac monitoring and arrhythmia analysis. Founded in 1989 and headquartered in Toronto with 1–10 employees, the company's product portfolio is anchored by two flagship platforms: GEMS FLEX, an ECG software platform for remote monitoring and cardiac analysis, and a 14-day Holter/LTCM platform that supports extended-wear and long-term continuous cardiac rhythm monitoring. Together these platforms target healthcare providers, cardiac care facilities, and remote patient monitoring use cases where extended cardiac assessment outside of clinical settings is required.

The company's revenue model is characterized as subscription/recurring for its ECG software platform, though specific pricing, contract terms, and customer counts are not publicly disclosed. CardioComm qualifies as a TSX-V reporting issuer with annual revenues under $10 million and is currently in a commercialization phase for its core products, funded in 2025 by a $512,000 insider loan facility from related parties (Xemxija Holdings, ITF Ventures, and CEO/director Etienne Grima) at 10% interest, secured against all company assets. The company has no disclosed institutional venture capital or private equity backing, and recent corporate actions — including debt settlement via share issuance to directors, stock option grants to the CEO, and a shift from quarterly to semi-annual financial reporting under Coordinated Blanket Order 51-933 — are consistent with a small, capital-constrained issuer.

Short descriptiontext

CardioComm Solutions is a Canadian TSX-V-listed developer of proprietary ECG software platforms (GEMS FLEX and a 14-day Holter/LTCM platform) for remote cardiac monitoring and arrhythmia analysis, serving healthcare providers and remote patient monitoring use cases.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNorth York, Canada
HQ citystring
North York
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
ECG software, cardiac monitoring, arrhythmia detection, Holter monitoring, remote patient monitoring
Industry2 codes
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
NAICS code1 code
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Cardiac Monitoring Software
No data
Revenue model1 record
1ECG Software Platform
TypeSubscription Recurring
Description

Commercialization of proprietary ECG software platform for remote monitoring and ECG analysis products

tipranks.com
Cost components3 values
Technology or R&D, Personnel, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1GEMS FLEX
Description

ECG software platform being developed and commercialized by CardioComm Solutions

newsfilecorp.com
+1 more record
Core offering1 text field

CardioComm Solutions develops and commercializes proprietary ECG (electrocardiogram) software platforms for remote cardiac monitoring and analysis. The company's flagship offerings—GEMS FLEX and the 14-Day Holter/LTCM Platform—enable healthcare providers to capture, transmit, and analyze cardiac rhythm data for arrhythmia detection, including extended-wear continuous monitoring of up to 14 days for patients both in clinical settings and remotely.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

CardioComm Solutions, Inc. is a healthcare technology company offering ECG software platforms for remote cardiac monitoring and ECG analysis. The company operates a platform-based architecture centered on two flagship products: GEMS FLEX and the 14-Day Holter/LTCM Platform. These software solutions work together to provide comprehensive ECG monitoring capabilities, enabling remote patient monitoring and cardiac arrhythmia detection for healthcare providers.

Product and service2 records
1GEMS FLEX
CategoryECG Software Platform
Description

ECG software platform designed for remote cardiac monitoring and ECG analysis, targeting healthcare providers and cardiac care facilities for arrhythmia detection and remote patient monitoring workflows.

214-Day Holter/LTCM Platform
CategoryECG Software Platform
Description

ECG software platform for extended-wear Holter and long-term continuous cardiac monitoring, enabling up to 14 days of continuous cardiac rhythm recording and analysis for healthcare providers and remote patient monitoring use cases.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

AliveCor's KardiaMobile consumer/clinical ECG devices and cloud-based ECG analysis platform overlap with CardioComm's remote ECG monitoring and arrhythmia detection use cases, targeting both healthcare providers and remote/home-based patients.

TypeEmerging player
Description

Spacelabs provides Holter analysis software and ambulatory ECG monitoring systems used by cardiology practices, directly overlapping with CardioComm's core ECG analysis and arrhythmia detection workflow.

TypeEmerging player
Description

HeartBeam is a small public company developing credit-card-sized ECG devices and cloud-based cardiac arrhythmia detection software, making it a closely comparable micro-cap ECG software peer with similar scale and clinical focus.

TypeBroad incumbent
Description

GE HealthCare provides ECG carts, Holter analysis, and MUSE cardiology information systems that compete with CardioComm's ECG analysis and arrhythmia detection software in hospital and clinic settings.

TypeDirect peer
Description

iRhythm's Zio long-term continuous monitoring patch and ECG analytics software directly competes with CardioComm's 14-Day Holter/LTCM platform in ambulatory cardiac arrhythmia detection, sharing the same end customers (healthcare providers, RPM programs) and recurring-revenue software model.

TypeEmerging player
Description

Biotricity is a small-cap cardiac monitoring company with remote patient monitoring and ECG solutions (Bioflux), making it a closely comparable micro-cap peer in business model, customer segment, and scale.

TypeBroad incumbent
Description

Preventice's BodyGuardian remote cardiac monitoring suite competes with CardioComm's GEMS FLEX platform in ambulatory ECG and Holter monitoring; as part of Boston Scientific it benefits from substantially greater scale and channel reach.

TypeBroad incumbent
Description

Baxter (via Hillrom/Welch Allyn) offers connected cardiac/ECG monitoring tools used by hospitals and clinicians; its cardiac diagnostics solutions overlap with CardioComm's provider-facing ECG software.

TypeBroad incumbent
Description

Philips offers a broad portfolio of cardiac monitoring, ECG, and telehealth solutions including its remote patient monitoring program, overlapping with CardioComm's ECG software platforms but at significantly larger scale and as part of a wider healthtech portfolio.

TypeBroad incumbent
Description

Medtronic's cardiac diagnostics portfolio, including insertable cardiac monitors and LINQ family, addresses the same underlying arrhythmia detection market as CardioComm, albeit with implantable rather than external ECG software.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

CardioComm Solutions, Inc.

Cardiac Monitoring Softwarecardiocommsolutions.com

CardioComm Solutions is a Canadian TSX-V-listed developer of proprietary ECG software platforms (GEMS FLEX and a 14-day Holter/LTCM platform) for remote cardiac monitoring and arrhythmia analysis, serving healthcare providers and remote patient monitoring use cases.

What CardioComm Solutions, Inc. does

CardioComm Solutions, Inc. is a Canadian public company listed on the TSX Venture Exchange (ticker: EKG) that develops and commercializes proprietary ECG software platforms for remote cardiac monitoring and arrhythmia analysis. Founded in 1989 and headquartered in Toronto with 1–10 employees, the company's product portfolio is anchored by two flagship platforms: GEMS FLEX, an ECG software platform for remote monitoring and cardiac analysis, and a 14-day Holter/LTCM platform that supports extended-wear and long-term continuous cardiac rhythm monitoring. Together these platforms target healthcare providers, cardiac care facilities, and remote patient monitoring use cases where extended cardiac assessment outside of clinical settings is required.

The company's revenue model is characterized as subscription/recurring for its ECG software platform, though specific pricing, contract terms, and customer counts are not publicly disclosed. CardioComm qualifies as a TSX-V reporting issuer with annual revenues under $10 million and is currently in a commercialization phase for its core products, funded in 2025 by a $512,000 insider loan facility from related parties (Xemxija Holdings, ITF Ventures, and CEO/director Etienne Grima) at 10% interest, secured against all company assets. The company has no disclosed institutional venture capital or private equity backing, and recent corporate actions — including debt settlement via share issuance to directors, stock option grants to the CEO, and a shift from quarterly to semi-annual financial reporting under Coordinated Blanket Order 51-933 — are consistent with a small, capital-constrained issuer.

CardioComm Solutions, Inc. firmographics

Firmographics
Name
CardioComm Solutions, Inc.
Legal name
CardioComm Solutions, Inc.
Website
https://cardiocommsolutions.com
Company type
Public
Founded year
1989
Operating status
Operating
Headcount range
1–10 employees
Short description
CardioComm Solutions is a Canadian TSX-V-listed developer of proprietary ECG software platforms (GEMS FLEX and a 14-day Holter/LTCM platform) for remote cardiac monitoring and arrhythmia analysis, serving healthcare providers and remote patient monitoring use cases.
Ownership category
akta.pro rank

CardioComm Solutions, Inc. industry classification

Industry
Product category
Cardiac Monitoring Software
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHACAB
Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics
SECONDARYHLALAFAA
Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms

Keywords

  • ECG software
  • Cardiac monitoring
  • Arrhythmia detection
  • Holter monitoring
  • Remote patient monitoring

Where CardioComm Solutions, Inc. is headquartered

Location

Headquarters

HQ city
North York
HQ country
Canada
HQ region
North America

Markets served

CardioComm Solutions, Inc. business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations

Revenue model

  1. ECG Software Platform: Commercialization of proprietary ECG software platform for remote monitoring and ECG analysis products

CardioComm Solutions, Inc. product offering

Product offering

Core offering

CardioComm Solutions develops and commercializes proprietary ECG (electrocardiogram) software platforms for remote cardiac monitoring and analysis. The company's flagship offerings—GEMS FLEX and the 14-Day Holter/LTCM Platform—enable healthcare providers to capture, transmit, and analyze cardiac rhythm data for arrhythmia detection, including extended-wear continuous monitoring of up to 14 days for patients both in clinical settings and remotely.

Product overview

CardioComm Solutions, Inc. is a healthcare technology company offering ECG software platforms for remote cardiac monitoring and ECG analysis. The company operates a platform-based architecture centered on two flagship products: GEMS FLEX and the 14-Day Holter/LTCM Platform. These software solutions work together to provide comprehensive ECG monitoring capabilities, enabling remote patient monitoring and cardiac arrhythmia detection for healthcare providers.

Differentiator

Problem solved

Functional benefit

Brands

  • GEMS FLEX: ECG software platform being developed and commercialized by CardioComm Solutions
  • 14-day Holter/LTCM Platform

Products and services

  • GEMS FLEX ECG software platform designed for remote cardiac monitoring and ECG analysis, targeting healthcare providers and cardiac care facilities for arrhythmia detection and remote patient monitoring workflows.
  • 14-Day Holter/LTCM Platform ECG software platform for extended-wear Holter and long-term continuous cardiac monitoring, enabling up to 14 days of continuous cardiac rhythm recording and analysis for healthcare providers and remote patient monitoring use cases.

Companies that use CardioComm Solutions, Inc.

Customer profile

Segments2 records

Ideal customer profiles1 record

CardioComm Solutions, Inc. technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

CardioComm Solutions, Inc. partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

CardioComm Solutions, Inc. competitors and assessment

Company assessment

Direct peers

  • AliveCor: AliveCor's KardiaMobile consumer/clinical ECG devices and cloud-based ECG analysis platform overlap with CardioComm's remote ECG monitoring and arrhythmia detection use cases, targeting both healthcare providers and remote/home-based patients.
  • iRhythm Technologies: iRhythm's Zio long-term continuous monitoring patch and ECG analytics software directly competes with CardioComm's 14-Day Holter/LTCM platform in ambulatory cardiac arrhythmia detection, sharing the same end customers (healthcare providers, RPM programs) and recurring-revenue software model.

Emerging players

  • Spacelabs Healthcare: Spacelabs provides Holter analysis software and ambulatory ECG monitoring systems used by cardiology practices, directly overlapping with CardioComm's core ECG analysis and arrhythmia detection workflow.
  • HeartBeam: HeartBeam is a small public company developing credit-card-sized ECG devices and cloud-based cardiac arrhythmia detection software, making it a closely comparable micro-cap ECG software peer with similar scale and clinical focus.
  • Biotricity: Biotricity is a small-cap cardiac monitoring company with remote patient monitoring and ECG solutions (Bioflux), making it a closely comparable micro-cap peer in business model, customer segment, and scale.

Broad incumbents

  • GE HealthCare: GE HealthCare provides ECG carts, Holter analysis, and MUSE cardiology information systems that compete with CardioComm's ECG analysis and arrhythmia detection software in hospital and clinic settings.
  • Preventice Solutions (Boston Scientific): Preventice's BodyGuardian remote cardiac monitoring suite competes with CardioComm's GEMS FLEX platform in ambulatory ECG and Holter monitoring; as part of Boston Scientific it benefits from substantially greater scale and channel reach.
  • Hillrom / Baxter (Patient Monitoring): Baxter (via Hillrom/Welch Allyn) offers connected cardiac/ECG monitoring tools used by hospitals and clinicians; its cardiac diagnostics solutions overlap with CardioComm's provider-facing ECG software.
  • Philips (Cardiac Monitoring): Philips offers a broad portfolio of cardiac monitoring, ECG, and telehealth solutions including its remote patient monitoring program, overlapping with CardioComm's ECG software platforms but at significantly larger scale and as part of a wider healthtech portfolio.
  • Medtronic (Cardiac Diagnostics & Services): Medtronic's cardiac diagnostics portfolio, including insertable cardiac monitors and LINQ family, addresses the same underlying arrhythmia detection market as CardioComm, albeit with implantable rather than external ECG software.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

CardioComm Solutions, Inc. financial estimates

Financial estimate

Revenue estimate

Valuation estimate

CardioComm Solutions, Inc. leadership team

Management profile

Number of profiles

Profiles1 record

CardioComm Solutions, Inc. funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

CardioComm Solutions, Inc. M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CardioComm Solutions, Inc.

What does CardioComm Solutions, Inc. do?

CardioComm Solutions develops and commercializes proprietary ECG (electrocardiogram) software platforms for remote cardiac monitoring and analysis. The company's flagship offerings—GEMS FLEX and the 14-Day Holter/LTCM Platform—enable healthcare providers to capture, transmit, and analyze cardiac rhythm data for arrhythmia detection, including extended-wear continuous monitoring of up to 14 days for patients both in clinical settings and remotely.

Is CardioComm Solutions, Inc. a public or private company?

CardioComm Solutions, Inc. is a public company. It is classified as public and is currently operating.

When was CardioComm Solutions, Inc. founded?

CardioComm Solutions, Inc. was founded in 1989. It employs 1 to 10 people.

Where is CardioComm Solutions, Inc. based?

CardioComm Solutions, Inc. is headquartered in North York, Canada, in the North America region.

How does CardioComm Solutions, Inc. make money?

One revenue line is on record: ECG Software Platform.

Who are CardioComm Solutions, Inc.'s main competitors?

Direct peers on record are AliveCor and iRhythm Technologies. Emerging players are Spacelabs Healthcare, HeartBeam and Biotricity. Broad incumbents are GE HealthCare, Preventice Solutions (Boston Scientific), Hillrom / Baxter (Patient Monitoring), Philips (Cardiac Monitoring) and Medtronic (Cardiac Diagnostics & Services).

Does CardioComm Solutions, Inc. have an API?

No public API is recorded for CardioComm Solutions, Inc..

What industry is CardioComm Solutions, Inc. in?

CardioComm Solutions, Inc.'s product category is Cardiac Monitoring Software. Its primary akta.pro industry code is HLAHACAB, Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334510 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The future of tradingCardioComm Solutions, CancerCare Manitoba Launch Remote ECG Monitoring Pilot for Breast Cancer PatientsCardioComm Solutions and CancerCare Manitoba launched a breast cancer home ECG monitoring pilot on October 19, 2026, using HeartCheck CardiBeat handheld monitors. The one-year study will assess whether remote monitoring improves cardiac safety, reduces hospital visits, and affects adverse events, with findings potentially prompting medication or treatment adjustments.AktienCardioComm Solutions and CancerCare Manitoba Launch Remote QT/QTc Interval Monitoring Pilot for Breast Cancer PatientsCardioComm Solutions and CancerCare Manitoba launched a pilot study using CardioComm's HeartCheck ECG monitor to remotely monitor QT/QTc intervals in breast cancer patients on certain therapies. The one-year study aims to reduce hospital visits and improve patient safety by detecting QT prolongation, which can lead to torsades de pointes.NewsfileCardioComm Solutions and Predictiv AI Enter into Strategic AI CollaborationCardioComm Solutions and Predictiv AI entered a strategic collaboration and joint development agreement. Predictiv AI will contribute AI and predictive analytics capabilities, while CardioComm provides medical software and regulatory expertise. The agreement preserves each company's IP and requires separate project schedules for commercial terms.Stock TitanCardioComm adopts semi-annual reporting in 2026CardioComm Solutions, Inc. has elected to rely on Coordinated Blanket Order 51-933 exemptions to move from quarterly to semi-annual financial reporting, effective for its fiscal year ending December 31, 2026. Under this voluntary framework, the company will be exempt from filing Q1 and Q3 interim financial reports while continuing to file audited annual statements and six-month interim reports. The company confirms it meets eligibility criteria including annual revenues under $10 million and at least 12 months of reporting issuer status in Canada.NewsfileCardioComm Receives TSX Venture Exchange Approval for Announced Loan FacilityCardioComm Solutions has received TSX Venture Exchange approval for a $512,000 loan facility to fund the completion and commercialization of its GEMS FLEX and 14-day Holter ECG software platform, which the company expects to become its principal offering and major revenue source. As part of the loan agreement, the company issued 345,600 bonus shares and 6,912,000 bonus warrants to lenders Xemxija Holdings Inc. and ITF Ventures Inc., both controlled by directors of CardioComm. The transaction qualifies as a related party transaction under Canadian securities regulations (MI 61-101), which provided exemptions from formal valuation and minority shareholder approval requirements.The Globe and MailCardioComm Secures $512,000 Loan to Advance ECG Software PlatformCardioComm Solutions has terminated a previously announced royalty agreement and secured a $512,000 loan from insiders to advance its GEMS FLEX and 14-day Holter/LTCM ECG software platform. The funding is intended to enable the company to finalize and commercialize its flagship product, which the company expects to become a major revenue source and enhance its market position in remote monitoring and ECG analysis capabilities.TipranksCardioComm Secures $512,000 Loan to Advance ECG Software PlatformCardioComm Solutions has terminated a previously announced royalty agreement and secured a $512,000 loan from insiders to advance its GEMS FLEX and 14-day Holter/LTCM ECG software platform. The funding will enable the company to finalize and commercialize this flagship product, which is expected to serve as a major revenue source and enhance its market position in remote monitoring and ECG analysis capabilities. The company describes itself as a global provider of consumer heart monitoring and medical electrocardiogram software solutions.